 Senseonics revolutionary Eversense glucose monitor may be redefining diabetes treatment, but its current contribution doesnt justify SENS stock rich valuation. The post Senseonics Financials Dont Support Its Billion-Dollar-Plus Market Cap appeared first on InvestorPlace. 